Diagnostic Laboratory Services, INC

Diagnostic Laboratory Services, INC was paid $45.98M by Medicaid between Jan 2018 and Dec 2024, across 300 billing codes. Its largest line is 80061, Lipid panel — 7.3% of everything it billed.

33Billing provider infoDIAGNOSTIC LABORATORY SERVICES, INC
AIEA, HI 96701

33aNPI1215930987assigned 05/24/2005

33bProvider typeClinical Medical Laboratory

28Total paid$45.98M

24GClaims4,026,114

24DCodes billed300

24AFirst – last monthJan 2018 – Dec 2024

Compared with peers

Next to other Clinical Medical Laboratory providers in Hawaii

Rank by total paid#1 of 18

Median peer was paid$163K

This provider vs. median282×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	547,900	$6.59M
2019	567,402	$6.33M
2020	520,658	$6.21M
2021	600,916	$7.07M
2022	536,291	$6.10M
2023	597,809	$6.41M
2024incomplete	655,138	$7.26M

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
80061	Lipid panel	7.3%	285,864	272,249	$3.36M
U0003	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r	5.4%	38,937	36,325	$2.46M
83036	Hemoglobin; glycosylated (A1C)	4.7%	250,720	238,780	$2.15M
80050	General health panel	4.3%	60,964	59,039	$1.97M
87491	Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe	4.3%	50,759	48,173	$1.96M
85025	Blood count; complete (CBC), automated, and automated differential WBC count	4.2%	299,074	265,068	$1.95M
87591	Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe	4.1%	49,617	47,043	$1.88M
80053	Comprehensive metabolic panel	3.9%	230,785	211,784	$1.81M
86003		3.5%	12,567	8,349	$1.59M
84443	Thyroid stimulating hormone (TSH)	3.2%	114,640	108,289	$1.49M
82306	Vitamin D; 25 hydroxy, includes fraction(s), if performed	3.1%	60,202	56,986	$1.43M
87502	Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets	2.1%	10,926	10,460	$945K

288 more codes

36415	Collection of venous blood by venipuncture	1.8%	419,127	$809K
87086	Culture, bacterial; quantitative colony count, urine	1.3%	76,751	$599K
87389	Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies	1.2%	22,888	$554K
87635	Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe	1.2%	12,051	$552K
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	1.2%	13,972	$541K
87624	Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types	1.2%	15,318	$529K
84439		1.1%	63,960	$522K
88142		1.0%	20,976	$476K
83970		<1%	16,187	$457K
84153		<1%	27,168	$436K
84403		<1%	16,496	$432K
82570		<1%	97,433	$422K
86803		<1%	29,041	$418K
82043		<1%	85,546	$414K
87186		<1%	46,953	$398K
87653		<1%	10,061	$392K
82607		<1%	28,494	$373K
81001		<1%	127,102	$362K
87340		<1%	33,225	$354K
87536		<1%	4,248	$339K
80048	Basic metabolic panel (calcium, ionized)	<1%	54,466	$336K
82728		<1%	30,038	$324K
87070		<1%	34,264	$315K
87517		<1%	6,809	$294K
86762		<1%	16,981	$269K
84402		<1%	9,814	$261K
82746		<1%	20,444	$256K
87088		<1%	34,445	$246K
83550		<1%	30,560	$235K
86850		<1%	15,655	$228K
82670		<1%	7,408	$227K
87480		<1%	10,183	$218K
87510		<1%	10,159	$213K
86702		<1%	14,306	$212K
86706		<1%	18,339	$208K
83880		<1%	8,367	$207K
82105		<1%	12,947	$206K
84550		<1%	60,113	$205K
87077		<1%	21,141	$204K
87660		<1%	10,063	$202K
86592		<1%	41,541	$195K
85027		<1%	33,927	$194K
83540		<1%	33,329	$191K
86704		<1%	15,153	$188K
83655		<1%	12,284	$185K
83013		<1%	2,649	$184K
87390		<1%	9,875	$184K
86038		<1%	15,125	$177K
87522	Neg quan hep c or qual rna	<1%	4,144	$173K
82274		<1%	12,587	$173K
86359		<1%	4,882	$172K
84702		<1%	10,034	$161K
86360		<1%	3,638	$161K
86008		<1%	2,207	$148K
84146		<1%	6,950	$148K
84480		<1%	10,532	$142K
86701		<1%	14,323	$139K
82785		<1%	7,762	$138K
83001		<1%	6,814	$138K
86480		<1%	2,905	$135K
88143		<1%	6,284	$135K
83735		<1%	23,396	$134K
86235		<1%	2,395	$132K
85610		<1%	35,965	$129K
86787		<1%	8,945	$127K
80074		<1%	2,592	$118K
84481		<1%	7,341	$117K
U0005	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2	<1%	5,652	$111K
86160		<1%	9,273	$101K
86140		<1%	20,131	$99K
86708		<1%	7,696	$99K
87651	Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe	<1%	2,608	$99K
86901		<1%	16,398	$90K
82378		<1%	5,833	$88K
83002		<1%	4,301	$84K
86696		<1%	3,546	$75K
82533		<1%	4,616	$72K
82652		<1%	1,976	$71K
84144		<1%	3,287	$71K
87902		<1%	308	$69K
82677		<1%	2,338	$65K
80069		<1%	11,859	$65K
87205		<1%	15,209	$64K
86695		<1%	4,386	$62K
85730		<1%	11,173	$61K
80076		<1%	8,766	$58K
84460		<1%	20,117	$56K
86431		<1%	10,118	$56K
82950		<1%	10,361	$55K
87040		<1%	5,088	$53K
86900		<1%	16,418	$52K
85652		<1%	21,302	$52K
83690		<1%	7,620	$52K
82627		<1%	2,494	$51K
82672		<1%	2,123	$51K
86735		<1%	3,197	$49K
86225		<1%	3,592	$47K
86765		<1%	3,118	$47K
84165		<1%	6,402	$45K
83525		<1%	4,108	$45K
87634		<1%	612	$44K
86800		<1%	2,879	$44K
82550		<1%	10,600	$44K
82951		<1%	3,110	$43K
84450		<1%	14,360	$42K
86376		<1%	2,787	$41K
82248		<1%	22,970	$40K
G0103	Prostate cancer screening; prostate specific antigen test (psa)	<1%	4,060	$40K
82977		<1%	7,822	$40K
82784		<1%	5,376	$39K
83520		<1%	2,637	$38K
87209		<1%	2,271	$38K
87529		<1%	974	$37K
84681		<1%	1,767	$37K
84100		<1%	13,536	$36K
84156		<1%	14,037	$36K
83090		<1%	2,779	$35K
83615		<1%	7,412	$35K
G0480	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed	<1%	1,084	$34K
80159		<1%	3,271	$33K
82150		<1%	4,943	$32K
85018		<1%	13,192	$32K
84703		<1%	3,603	$31K
84425		<1%	1,677	$30K
86317		<1%	936	$30K
85014		<1%	12,525	$29K
86336		<1%	1,814	$29K
80164		<1%	2,721	$29K
86677		<1%	1,873	$29K
87046		<1%	3,223	$29K
83516		<1%	2,047	$28K
80197		<1%	3,481	$28K
84432		<1%	1,894	$28K
87177		<1%	2,988	$27K
87633	Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets	<1%	71	$27K
86304		<1%	1,351	$26K
U0002	2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc	<1%	680	$25K
82024		<1%	721	$25K
84154		<1%	1,702	$24K
81025		<1%	3,043	$24K
84166		<1%	1,740	$23K
82565		<1%	7,581	$23K
82947		<1%	6,931	$23K
86300		<1%	1,054	$22K
87045		<1%	2,261	$22K
86200		<1%	1,850	$22K
83014		<1%	2,614	$22K
84484		<1%	2,194	$21K
84445		<1%	666	$21K
83721		<1%	2,465	$20K
86021		<1%	1,399	$18K
83521		<1%	1,390	$18K
87899		<1%	1,356	$18K
36416		<1%	7,338	$18K
85379		<1%	1,887	$18K
87081		<1%	2,583	$17K
85651		<1%	4,008	$16K
84270		<1%	1,331	$16K
87338		<1%	1,125	$16K
86709		<1%	1,378	$16K
87798	Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism	<1%	449	$16K
83921		<1%	1,206	$16K
82465		<1%	4,155	$16K
86665		<1%	400	$16K
87350		<1%	1,171	$15K
87799		<1%	879	$15K
87427		<1%	1,382	$15K
86334		<1%	1,053	$14K
84134		<1%	1,351	$14K
83718		<1%	1,567	$13K
87880	Infectious agent antigen detection by immunoassay; Streptococcus, group A	<1%	801	$13K
83605		<1%	1,231	$13K
85045		<1%	3,883	$13K
84482		<1%	836	$12K
82952		<1%	2,591	$11K
86707		<1%	859	$11K
86147		<1%	213	$10K
86361		<1%	552	$10K
87341		<1%	902	$10K
86036		<1%	1,008	$10K
83021		<1%	616	$10K
82103		<1%	771	$10K
83010		<1%	980	$10K
86381		<1%	470	$10K
82310		<1%	2,703	$9K
83883		<1%	589	$9K
87116		<1%	1,361	$9K
84520		<1%	3,775	$9K
82140		<1%	799	$9K
80178		<1%	1,463	$9K
86301		<1%	620	$9K
86141		<1%	2,271	$9K
84155		<1%	3,784	$8K
82390		<1%	790	$8K
86364		<1%	717	$8K
87807		<1%	586	$7K
86593		<1%	1,499	$7K
82610		<1%	662	$7K
86705		<1%	525	$7K
87015		<1%	1,476	$7K
86255		<1%	436	$7K
87324		<1%	569	$6K
87075		<1%	694	$6K
87449		<1%	559	$6K
87206		<1%	1,559	$6K
82232		<1%	673	$6K
82040		<1%	1,591	$5K
84478		<1%	1,163	$5K
84132		<1%	1,821	$5K
86015		<1%	519	$5K
82247		<1%	1,292	$5K
80305		<1%	988	$5K
0202U	Oncology (prostate), multianalyte, gene expression profiling	<1%	39	$5K
81015		<1%	1,502	$4K
87497		<1%	131	$4K
85049		<1%	851	$4K
84207		<1%	200	$4K
83825		<1%	227	$4K
83020		<1%	379	$4K
84145		<1%	173	$4K
86769		<1%	497	$3K
84075		<1%	902	$3K
81003		<1%	1,246	$3K
82175		<1%	140	$3K
86341		<1%	115	$3K
84300		<1%	655	$2K
83993		<1%	123	$2K
84466		<1%	240	$2K
86663		<1%	157	$2K
86664		<1%	131	$2K
84305		<1%	93	$2K
84436		<1%	288	$2K
80162		<1%	202	$2K
84244		<1%	85	$2K
82088		<1%	42	$2K
U0001	Cdc 2019 novel coronavirus (2019-ncov) real-time rt-pcr diagnostic panel	<1%	74	$2K
86835		<1%	18	$2K
83930		<1%	337	$2K
80051		<1%	391	$2K
87184		<1%	271	$2K
87269		<1%	126	$2K
85613		<1%	152	$2K
86308		<1%	198	$1K
G0328	Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous	<1%	1,921	$1K
84630		<1%	123	$1K
85048		<1%	599	$1K
G0123	Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, screening by cytotechnologist under physician supervision	<1%	554	$1K
82542		<1%	60	$1K
87481		<1%	21	$960.90
81050		<1%	372	$919.47
82668		<1%	89	$873.14
86692		<1%	45	$872.07
83498		<1%	29	$789.01
86060		<1%	101	$773.13
87801	Infectious agent detection by nucleic acid; amplified probe, multiple organisms	<1%	21	$737.49
84295		<1%	409	$728.41
83935		<1%	146	$705.56
80177		<1%	73	$631.84
87102		<1%	68	$609.73
82985		<1%	56	$582.66
86337		<1%	24	$515.08
82525		<1%	51	$503.26
82340		<1%	84	$487.47
80202		<1%	41	$460.22
G0499	Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result	<1%	28	$385.95
86880		<1%	54	$366.00
82507		<1%	15	$363.77
80143		<1%	27	$300.62
82166		<1%	15	$293.52
82803		<1%	16	$289.54
84133		<1%	81	$259.86
82530		<1%	16	$251.03
86780		<1%	16	$247.15
80156		<1%	19	$236.52
83945		<1%	17	$191.91
84590		<1%	16	$177.24
82435		<1%	80	$163.83
83519		<1%	12	$155.31
82397		<1%	14	$136.37
84560		<1%	29	$126.79
82374		<1%	38	$117.08
82575		<1%	12	$109.89
S9999	Sales tax	<1%	52,329	$94.25
84105		<1%	14	$68.65
85004		<1%	15	$61.14
84392		<1%	14	$49.58
83986		<1%	13	$43.28
87661	Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe	<1%	15	$28.72

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialROBERTS, REBECCA (VP FINANCE)